Cited by 1,558SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesCOVID-19 Clinical Research Studies

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Spike mutation D614G alters SARS-CoV-2 fitness

Open access

Plante, Jessica A., Liu, Yang, Liu, Jianying, Xia, Hongjie, Johnson, Bryan A., Lokugamage, Kumari G., Zhang, Xianwen, Muruato, Antonio E., Zou, Jing, Fontes-Garfias, Camila R., Mirchandani, Divya, Scharton, Dionna, Bilello, John P., Ku, Zhiqiang, An, Zhiqiang, Kalveram, Birte, Freiberg, Alexander N., Menachery, Vineet D., Xie, Xuping, Plante, Kenneth S., Weaver, Scott C., Shi, Pei-Yong·2021·Nature

DOI 10.1038/s41586-020-2895-3PMC PMC8158177

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein substitution D614G became dominant during the coronavirus disease 2019 (COVID-19) pandemic 1,2. However, the effect of this variant on viral spread and vaccine efficacy remains to be defined. Here we engineered the spike D614G substitution in the USA-WA1/2020 SARS-CoV-2 strain, and found that it enhances viral replication in human lung epithelial cells and primary human airway tissues by increasing the infectivity and stability of virions. Hamsters infected with SARS-CoV-2 expressing spike(D614G) (G614 virus) produced higher infectious titres in nasal washes and the trachea, but not in the lungs, supporting clinical evidence showing that the mutation enhances viral loads in the upper respiratory tract of COVID-19 patients and may increase transmission. Sera from hamsters infected with D614 virus exhibit modestly higher neutralization titres against G614 virus than against D614 virus, suggesting that the mutation is unlikely to reduce the ability of vaccines in clinical trials to protect against COVID-19, and that therapeutic antibodies should be tested against the circulating G614 virus. Together with clinical findings, our work underscores the importance of this variant in viral spread and its implications for vaccine efficacy and antibody therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41586-020-2895-3

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,237
The New Statistics: Why and How
Cumming, G. (2014) · Psychological Science · doi:10.1177/0956797613504966 · Cited by 3,200
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
HCA Lung Biological Network, Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0868-6 · Cited by 2,501
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.022 · Cited by 1,852
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report
Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., et al. (2020) · doi:10.1101/2020.06.30.20142570 · Cited by 1,569
Self-citation
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Hou, Y. J., Okuda, K., Edwards, C. E., Martinez, D. R., Asakura, T., Dinnon, K. H., Kato, T., Lee, R. E., Yount, B. L., Mascenik, T. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.042 · Cited by 1,488

Show all 37 references

Research works printed but not linked: 1

Mulligan, M. J. et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 586, 589–593 (2020). · DOI · Paper page

Sorted by citations

Items 901–1,000 of 1,008

Jumping a Moving Train: SARS-CoV-2 Evolution in Real Time
Moustafa, A. M., & Planet, P. J. (2021) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piab051 · Cited by 8
Dynamics prediction of emerging notable spike protein mutations in SARS-CoV-2 implies a need for updated vaccines
Al-Zyoud, W. A., & Haddad, H. I. (2021) · Biochimie · doi:10.1016/j.biochi.2021.08.011 · Cited by 9
Whole Genome Sequencing of SARS-CoV-2 Strains in COVID-19 Patients From Djibouti Shows Novel Mutations and Clades Replacing Over Time
Osman, I. O., Levasseur, A., Bréchard, L., Hassan, I. A., Abdillahi, I. S., Waberi, Z. A., Delerce, J., Bedotto, M., Houhamdi, L., Fournier, P., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.737602 · Cited by 8
SARS-CoV-2 transgressing LncRNAs uncovers the known unknowns
Shukla, N., Prasad, A., Kanga, U., Suravajhala, R., Nigam, V. K., Kishor, P. B. K., Polavarapu, R., Chaubey, G., Singh, K. K., & Suravajhala, P. (2021) · Physiological Genomics · doi:10.1152/physiolgenomics.00075.2021 · Cited by 8
A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) Variant
To, A., Wong, T. A. S., Lieberman, M. M., Thompson, K. S., Ball, A. H., Pessaint, L., Greenhouse, J. J., Daham, N., Cook, A., Narvaez, B., et al. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00600 · Cited by 8
Analysis of SARS-CoV-2 variants B.1.617: host tropism, proteolytic activation, cell–cell fusion, and neutralization sensitivity
Zhang, L., Li, Q., Wu, J., Yu, Y., Zhang, Y., Nie, J., Liang, Z., Cui, Z., Liu, S., Wang, H., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2054369 · Cited by 10
Cross-variant protection against SARS-CoV-2 infection in hamsters immunized with monovalent and bivalent inactivated vaccines
Ye, Z., Fan, Y., Tang, K., Ong, C. P., Luo, C., Chung, H.-L., Leong, T.-L., Liang, R., Lui, W., Zhou, R., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72109 · Cited by 8
Recipients of COVID-19 vaccines face challenges of SARS-CoV-2 variants
Li, T., & Luo, K. Q. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72424 · Cited by 8
Genomic Surveillance of SARS-CoV-2 in the Southern Province of Zambia: Detection and Characterization of Alpha, Beta, Delta, and Omicron Variants of Concern
Katowa, B., Kalonda, A., Mubemba, B., Matoba, J., Shempela, D. M., Sikalima, J., Kabungo, B., Changula, K., Chitanga, S., Kasonde, M., et al. (2022) · Viruses · doi:10.3390/v14091865 · Cited by 8
Sequence analysis of SARS-CoV-2 Delta variant isolated from Makassar, South Sulawesi, Indonesia
Massi, M. N., Sjahril, R., Halik, H., Soraya, G. V., Hidayah, N., Pratama, M. Y., Faruk, M., Handayani, I., Gazali, F. M., Hakim, M. S., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13382 · Cited by 8
Preparation and characterization of nanobodies targeting SARS-CoV-2 papain-like protease
Qiao, H., Li, L., Wang, L., Yu, H., Hu, F., Zhou, X., Yang, H., Xu, J., Meng, X., Geng, Y., et al. (2023) · Protein Expression and Purification · doi:10.1016/j.pep.2023.106267 · Cited by 8
Changes within the P681 residue of spike dictate cell fusion and syncytia formation of Delta and Omicron variants of SARS-CoV-2 with no effects on neutralization or infectivity
Kuzmina, A., Korovin, D., Cohen-Lass, I., Atari, N., Ottolenghi, A., Hu, P., Mandelboim, M., Rosental, B., Rosenberg, E., Diaz‐Griffero, F., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16750 · Cited by 8
CRISPR-based engineering of RNA viruses
Nemudryi, A. A., Nemudraia, A., Nichols, J. E., Scherffius, A. M., Zahl, T., & Wiedenheft, B. (2023) · Science Advances · doi:10.1126/sciadv.adj8277 · Cited by 8
Educating ethically during COVID-19
Pilkington, B., Wilkins, V., & Nichols, D. B. (2021) · International Journal of Ethics Education · doi:10.1007/s40889-021-00120-8 · Cited by 8
In Silico Study of Mutational Stability of SARS-CoV-2 Proteins
Chaudhuri, D., Majumder, S., Datta, J., & Giri, K. (2021) · The Protein Journal · doi:10.1007/s10930-021-09988-3 · Cited by 8
SARS-CoV-2 genome sequencing from COVID-19 in Ecuadorian patients: a whole country analysisPreprint
Márquez, S., Prado-Vivar, B., Guadalupe, J. J., Becerra-Wong, M., Gutiérrez, B., Fernández‐Cadena, J. C., Andrade-Molina, D., Gabriel Morey-León, G., Moncayo, M., Guevara, R., et al. (2021) · medRxiv · doi:10.1101/2021.03.19.21253620 · Cited by 8
SARS-COV-2 γ variant acquires spike P681H or P681R for improved viral fitnessPreprint
Yang, X. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.16.464641 · Cited by 8
Early detection of highly transmissible viral variants using phylogenomics
May, M. R., & Rannala, B. H. (2024) · Science Advances · doi:10.1126/sciadv.adk7623 · Cited by 7
Pathogenesis and transmission of SARS-CoV-2 D614G, Alpha, Gamma, Delta, and Omicron variants in golden hamsters
Banete, A., Griffin, B. D., Corredor, J. C., Chien, E., Yip, L., Gunawardena, T. N. A., Nirmalarajah, K., Liang, J., Lee, Y., Leacy, A., et al. (2025) · npj Viruses · doi:10.1038/s44298-025-00092-2 · Cited by 8
D614G reshapes allosteric networks and opening mechanisms of SARS-CoV-2 spikes
Kearns, F. L., Bogetti, A. T., Calvó‐Tusell, C., Braza, M. K. E., Casalino, L., Gramm, A. J., Braet, S. M., Rosenfeld, M. A., Rajapaksha, H., Barker, B., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2504793123 · Cited by 7
The Integration of Nanotechnology, Artificial Intelligence (AI), Machine Learning (ML) and 3D-Bioprinting Approaches for Personalized COVID-19 Treatment
Uddin, M. J., Gholap, A. D., Khan, T., Proma, A. Y., Masud, S., Choonara, Y. E., Gowri, S. S., Webster, T. J., & Faiyazuddin, M. (2024) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2024.3933 · Cited by 8
Convergent evolution in nucleocapsid facilitated SARS-CoV-2 adaptation for human infection
Lokugamage, K. G., Zhou, Y., Alvarado, R. E., Plante, J. A., Ahearn, Y. P., Chen, J. C., Estes, L. K., Meyers, W. M., Nilsson, J., Routh, A. L., et al. (2025) · Journal of Virology · doi:10.1128/jvi.02091-24 · Cited by 7
Self-citation
Bat sarbecovirus WIV1-CoV bears an adaptive mutation that alters spike dynamics and enhances ACE2 binding
Tse, A. L., Lasso, G., Berrigan, J. L., McLellan, J. S., Chandran, K., & Miller, E. H. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013123 · Cited by 7
The Longest Infectious Virus Shedding in a Child Infected With the G614 Strain of SARS-CoV-2
Bal, Z. Ş., Özkul, A., Bilen, N. M., Kurugöl, Z., & Özkınay, F. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003158 · Cited by 7
Introduction of SARS‐CoV‐2 C.37 (WHO VOI lambda) in the Sao Paulo State, Southeast Brazil
Kashima, S. H., Slavov, S. N., Giovanetti, M., Rodrigues, E. S., Patané, J. S. L., Viala, V. L., Santos, E. V., Evaristo, M., de Lima, L. P. O., Martins, A. J., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27389 · Cited by 7
Temporal-Geographical Dispersion of SARS-CoV-2 Spike Glycoprotein Variant Lineages and Their Functional Prediction Using in Silico Approach
Boon, S. S., Xia, C., Wang, M. H., Yip, K. L., Luk, H. Y., Li, S., Ng, R. W. Y., Lai, C. K. C., Chan, P. K. S., & Chen, Z. (2021) · mBio · doi:10.1128/mbio.02687-21 · Cited by 7
A review of epidemiology, clinical features and disease course, transmission dynamics, and neutralization efficacy of SARS-CoV-2 variants
Deb, P., Molla, M. M. A., Saif‐Ur‐Rahman, K., Das, M. C., & Das, D. (2021) · Egyptian Journal of Bronchology · doi:10.1186/s43168-021-00090-x · Cited by 7
Interference reduction isothermal nucleic acid amplification strategy for COVID-19 variant detection
Li, G., Ko, C.-N., Wang, Z., Chen, F., Wang, W., Ma, D., & Leung, C. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.133006 · Cited by 7
Phase I randomized, observer-blinded, placebo-controlled study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
Martín‐Orozco, N., Vale, N., Mihic, A., Amor, T., Reiter, L., Arita, Y., Samson, R., Hu, Q., Gingras, A., Sorenson, B., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-35662-y · Cited by 9
Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2
Kim, D., Kim, J.-S., Kim, M., Park, H., Maharjan, S., Baek, K., Kang, B. M., Kim, S., Park, S., Park, M., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1280686 · Cited by 7
Evolution at Spike protein position 519 in SARS-CoV-2 facilitated adaptation to humans
Cereghino, C., Michalak, K., DiGiuseppe, S., Guerra, J., Yu, D., Faraji, A. R., Sharp, A. K., Brown, A. M., Kang, L., Weger‐Lucarelli, J., et al. (2024) · npj Viruses · doi:10.1038/s44298-024-00036-2 · Cited by 7
Research progress of spike protein mutation of SARS-CoV-2 mutant strain and antibody development
Huan, X., Zhan, J., & Gao, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1407149 · Cited by 8
Severe Acute Respiratory Syndrome Coronavirus 2: The Emergence of Important Genetic Variants and Testing Options for Clinical Laboratories
Buchan, B. W., & Yao, J. D. C. (2021) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2021.05.004 · Cited by 7
Comparative study of predicted miRNA between Indonesia and China (Wuhan) SARS-CoV-2: a bioinformatics analysis
Rahmadi, A. P., Fasyah, I., Sudigyo, D., Budiarto, A., Mahesworo, B., Hidayat, A. A., & Pardamean, B. (2021) · Genes & Genomics · doi:10.1007/s13258-021-01119-7 · Cited by 7
SARS-CoV-2 in Transit: Characterization of SARS-CoV-2 Genomes From Venezuelan Migrants in Colombia
Patiño, L. H., Ballesteros, N., Muñoz, M., Castañeda, S., Hernández, C., Gomez, S., Flórez, C., Rico, A., Pardo, L., Hernández‐Pereira, C. E., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.07.069 · Cited by 7
Polyphenylene carboxymethylene (PPCM) microbicide repurposed as antiviral against SARS-CoV-2. Proof of concept in primary human undifferentiated epithelial cells
Escaffre, O., & Freiberg, A. N. (2021) · Antiviral Research · doi:10.1016/j.antiviral.2021.105162 · Cited by 7
Self-citation
Unmethylated CpG motif-containing genomic DNA fragments of bacillus calmette-guerin improves immune response towards a DNA vaccine for COVID-19
Zhou, Z., Zhang, X., Li, Q., Fu, L., Wang, M., Liu, S., Wu, J., Nie, J., Zhang, L., Zhao, C., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.08.103 · Cited by 7
Self-citation
Analyzing the effect of mutations in SARS-CoV2 papain-like protease from Saudi isolates on protein structure and drug-protein binding: Molecular modelling and dynamics studies
Alabbas, A. B., & Alamri, M. A. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.09.028 · Cited by 8
Identification of genotypic variants and its proteomic mutations of Brazilian SARS-CoV-2 isolates
Prathiviraj, R., Chellapandi, P., Begum, A., Kiran, G. S., & Selvin, J. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198618 · Cited by 7
Transmission dynamics and successful control measures of SARS-CoV-2 in the mega-size city of Guangzhou, China
Zhao, H., Zhang, Z., Lun, W., Chen, Z., Lu, X., Li, J., Qiu, F., Li, S., Mao, C., Lu, Y., et al. (2021) · Medicine · doi:10.1097/md.0000000000027846 · Cited by 7
Emergence of two distinct variants of SARS-CoV-2 and an explosive second wave of COVID-19: the experience of a tertiary care hospital in Pune, India
Shrivastava, S., Mhaske, S. T., Modak, M. S., Virkar, R., Pisal, S. S., Mishra, A. C., & Arankalle, V. A. (2022) · Archives of Virology · doi:10.1007/s00705-021-05320-7 · Cited by 7
Mutations in the genome of severe acute respiratory syndrome coronavirus 2: implications for COVID-19 severity and progression
Al-Qahtani, A. A. (2022) · Journal of International Medical Research · doi:10.1177/03000605221086433 · Cited by 8
Understanding the mutational frequency in SARS-CoV-2 proteome using structural features
Rawat, P., Sharma, D., Pandey, M., Prabakaran, R., & Gromiha, M. M. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105708 · Cited by 7
Inactivation of SARS-CoV-2 by charged particles for Future Vaccine Production Applications: A Monte Carlo study
Rafiepour, P., Sina, S., & Mortazavi, S. M. J. (2022) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2022.110265 · Cited by 7
Quinolizidines as Novel SARS-CoV-2 Entry Inhibitors
Huang, L., Zhu, L., Xie, H., Goodwin, J. S., Rana, T., Xie, L., & Chen, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179659 · Cited by 7
Comparison of Intracellular Transcriptional Response of NHBE Cells to Infection with SARS-CoV-2 Washington and New York Strains
Scott, T. M., Solis‐Leal, A., Lopez, J. B., Robison, R. A., Berges, B. K., & Pickett, B. E. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1009328 · Cited by 7
Comparison of Dose–Response Relationships for Two Isolates of SARS-CoV-2 in a Nonhuman Primate Model of Inhalational COVID-19
Dabisch, P. A., Sanjak, J. S., Boydston, J. A., Yeager, J. J., Herzog, A., Biryukov, J., Beck, K., Do, D. C., Seman, B. G., Green, B., et al. (2022) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2022.0043 · Cited by 6
Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19
Valenzuela-Fernández, A., Cabrera-Rodríguez, R., Ciuffreda, L., Pérez-Yanes, S., Estévez‐Herrera, J., González‐Montelongo, R., Alcoba-Flórez, J., Trujillo‐González, R., de Artola, D. G.-M., Gil-Campesino, H., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1052436 · Cited by 8
Multiplex Assays Enable Simultaneous Detection and Identification of SARS-CoV-2 Variants of Concern in Clinical and Wastewater Samples
Liu, Y., Kumblathan, T., Joyce, M., Tyrrell, D. L., Tipples, G. A., Pang, X., Li, X., & Le, X. C. (2023) · ACS Measurement Science Au · doi:10.1021/acsmeasuresciau.3c00005 · Cited by 7
Self-citation
Soluble Angiotensin-Converting Enzyme 2 Protein Improves Survival and Lowers Viral Titers in Lethal Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection with the Delta Variant
Cianfarini, C. L., Hassler, L., Wysocki, J. A., Hassan, A., Nicolaescu, V. I., Elli, D., Gula, H., Ibrahim, A. M., Randall, G. C., Henkin, J., et al. (2024) · Cells · doi:10.3390/cells13030203 · Cited by 7
Advancements in SARS-CoV-2 detection: Navigating the molecular landscape and diagnostic technologies
Almulla, N., Soltane, R., Alasiri, A., Allayeh, A. K., Alqadi, T., Alshehri, F., Alrokban, A. H., Zaghlool, S. S., Zayan, A. Z., Abdalla, K. F., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29909 · Cited by 7
Retracted
Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes
Braun, A., Rowntree, L. C., Huang, Z., Pandey, K., Thuesen, N. H., Li, C., Petersen, J., Littler, D. R., Raji, S., Nguyen, T. H. O., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51959-6 · Cited by 9
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2
Ruiz-Rodríguez, P., Francés-Gómez, C., Chiner‐Oms, Á., López, M. G., Jiménez-Serrano, S., Cancino‐Muñoz, I., Ruiz-Hueso, P., Torres‐Puente, M., Bracho, M. A., D’Auria, G., et al. (2021) · mBio · doi:10.1128/mbio.02315-21 · Cited by 8
Establishment and evaluation of a 30-minute detection method for SARS-CoV-2 nucleic acid using a novel ultra-fast real-time PCR instrument
Liu, W., Zhou, Z., Zhang, L., Li, L., Wang, L., Song, L., Qiu, S., Zhang, L., Xu, D., Tian, X., et al. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-21-1288 · Cited by 6
Self-citation
Genetic Surveillance of Five SARS-CoV-2 Clinical Samples in Henan Province Using Nanopore Sequencing
Wang, Y., Chen, D., Zhu, C., Zhao, Z., Gao, S., Gou, J., Guo, Y., & Kong, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.814806 · Cited by 7
The Emergence of SARS-CoV-2 Variants With a Lower Antibody Response: A Genomic and Clinical Perspective
Biswas, S., Mahmud, S., Mita, M. A., Afrose, S., Hasan, M. R., Paul, G. K., Shimu, M. S. S., Uddin, M. S., Zaman, S., Park, M. N., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.825245 · Cited by 6
SARS-CoV-2 receptor binding mutations and antibody mediated immunityPreprint
Mejdani, M., Haddadi, K., Pham, C., & Mahadevan, R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.25.427846 · Cited by 7
Effect of mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion functionPreprint
Barrett, C. T., Neal, H. E., Edmonds, K. L., Moncman, C. L., Thompson, R., Branttie, J. M., Boggs, K. B., Wu, C., Leung, D. W., & Dutch, R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.24.428007 · Cited by 7
Characterization of SARS-CoV-2 variants B.1.617.1 (Kappa), B.1.617.2 (Delta) and B.1.618 on cell entry, host range, and sensitivity to convalescent plasma and ACE2 decoy receptorPreprint
Ren, W., Ju, X., Gong, M., Lan, J., Yu, Y., Long, Q., Zhang, Y. L., Zhong, J., Zhong, G., Wang, X., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.03.458829 · Cited by 7
Distinct neutralizing kinetics and magnitudes elicited by different SARS-CoV-2 variant spikesPreprint
Liu, Y., Liu, J., Zou, J., Ren, P., Weaver, S. C., Xie, X., & Shi, P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.02.458740 · Cited by 6
Self-citation
Visible blue light inactivates SARS-CoV-2 variants and inhibits Delta replication in differentiated human airway epitheliaPreprint
Kocher, J., Arwood, L., Roberts, R. C., Henson, I., Annas, A., Emerson, D., Stasko, N., Fulcher, M. L., Brotton, M., Randell, S. H., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.25.477616 · Cited by 7
Stochastic modeling of COVID-19 spread in India: an approach incorporating logarithmic mean-reverting Ornstein-Uhlenbeck process with two-dose vaccine impact analysis
Midhun, T. A., Jose, S. A., Murugesan, K., & Jirawattanapanit, A. (2025) · Nonlinear Dynamics · doi:10.1007/s11071-025-10917-7 · Cited by 6
Vesicle-associated membrane protein 5 is an intrinsic defense factor for embryonic stem cells against coronaviruses
Dong, H., Pan, Z., Jiao, P., Ye, F., Peng, Q., Yu, Y., Lai, X., Li, H., Guan, Z., Deng, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61655-8 · Cited by 6
A single mutation may contribute to accelerated evolution of SARS-CoV-2 toward Omicron
Lin, X., Sha, Z., Zhang, C., Adler, J. M., Vidal, R. M., Langner, C., Fu, B., Xiong, Y., Tan, M., Jiang, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62300-0 · Cited by 6
Self-citation
Functional and structural basis of Omicron BA.3.2.1 spike
Wang, Y., Hu, Y., Chen, Z., Zou, J., Zhang, K., Ren, P., Shi, P., Liang, B., & Xie, X. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117812 · Cited by 6
Self-citation
Exposing structural variations in SARS-CoV-2 evolution
Yang, J., Zhang, P., Cheng, W. X., Lu, Y., Wu, G., & Ren, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-01650-3 · Cited by 6
Wastewater sequencing as a powerful tool to reveal SARS-CoV-2 variant introduction and spread in French Guiana, South America
Combe, M., Chérif, E., Deremarque, T., Rivera‐Ingraham, G. A., Seck-Thiam, F., Justy, F., Doudou, J.-C., Carod, J.-F., Carage, T., Procureur, A., et al. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.171645 · Cited by 6
CD81 fusion alters SARS-CoV-2 Spike trafficking
Cone, A. S., Zhou, Y., McNamara, R. P., Eason, A. B., Arias, G. F., Landis, J. T., Shifflett, K., Chambers, M. G., Yuan, R., Willcox, S., et al. (2024) · mBio · doi:10.1128/mbio.01922-24 · Cited by 6
Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain
Ying, B., Liang, C.-Y., Desai, P., Scheaffer, S. M., Elbashir, S. M., Edwards, D. K., Thackray, L. B., & Diamond, M. (2024) · Journal of Virology · doi:10.1128/jvi.00574-24 · Cited by 8
mRNA Technology in Modern Medicine: Review and Future Prospects
Silva, H. M. (2025) · Clinical and Molecular Epidemiology · doi:10.53964/cme.2025001 · Cited by 4
Virology, Immunity and Vaccine Development of SARS-CoV-2
Erganiş, S., & Bozdayı, G. (2021) · Archives of Current Medical Research · doi:10.47482/acmr.2021.8 · Cited by 6
Application of polymerase chain reaction-restriction fragment length polymorphism (RFLP-PCR) in the analysis of single nucleotide polymorphisms (SNPs)
Tarach, P. (2021) · Acta Universitatis Lodziensis Folia Biologica et Oecologica · doi:10.18778/1730-2366.16.14 · Cited by 10
Semi-Supervised Pipeline for Autonomous Annotation of SARS-CoV-2 Genomes
Beck, K. L., Seabolt, E., Agarwal, A., Nayar, G., Bianco, S., Krishnareddy, H., Ngo, T. A., Kunitomi, M., Mukherjee, V. V., & Kaufman, J. H. (2021) · Viruses · doi:10.3390/v13122426 · Cited by 5
A comprehensive update on the structure and synthesis of potential drug targets for combating the coronavirus pandemic caused by SARS‐CoV‐2
Malik, P., Jain, S., Jain, P., Kumawat, J., Dwivedi, J., & Kishore, D. (2022) · Archiv der Pharmazie · doi:10.1002/ardp.202100382 · Cited by 5
Requirements for a Bespoke Intensive Care Unit Dashboard in Response to the COVID-19 Pandemic: Semistructured Interview Study
Davidson, B. I., Portillo, K. M. F., Wac, M., McWilliams, C., Bourdeaux, C., & Craddock, I. J. (2022) · JMIR Human Factors · doi:10.2196/30523 · Cited by 8
The third international hackathon for applying insights into large-scale genomic composition to use cases in a wide range of organisms
Walker, K., Kalra, D., Lowdon, R. F., Chen, G., Molik, D. C., Soto, D. C., Dabbaghie, F., Khleifat, A. A., Mahmoud, M., Paulin, L. F., et al. (2022) · F1000Research · doi:10.12688/f1000research.110194.1 · Cited by 7
Mutations of the SARS-CoV-2 Spike Glycoprotein Detected in Cats and Their Effect on Its Structure and Function
Hamdy, M. E., El‐Deeb, A. H., Hagag, N. M., Shahein, M. A., Alaidi, O., & Hussein, H. A. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.875123 · Cited by 6
Full-genome sequencing and mutation analysis of SARS-CoV-2 isolated from Makassar, South Sulawesi, Indonesia
Massi, M. N., Abidin, R. S., Farouk, A., Halik, H., Soraya, G. V., Hidayah, N., Sjahril, R., Handayani, I., Hakim, M. S., Gazali, F. M., et al. (2022) · PeerJ · doi:10.7717/peerj.13522 · Cited by 7
Production of a functionally active recombinant SARS-CoV-2 (COVID-19) 3C-like protease and a soluble inactive 3C-like protease-RBD chimeric in a prokaryotic expression system
Veríssimo, C. D. M., Corrales, J. L., Dorey, A., Cwiklinski, K., Lalor, R., Calvani, N. E. D., Jewhurst, H., Flaus, A., Doyle, S., & Dalton, J. P. (2022) · Epidemiology and Infection · doi:10.1017/s0950268822001078 · Cited by 6
Physical-Chemical Regulation of Membrane Receptors Dynamics in Viral Invasion and Immune Defense
Qin, R., An, C., & Chen, W. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167800 · Cited by 6
A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 Variants
Hernandez, M., Banu, R., Shrestha, P., Gonzalez-Reiche, A., van de Guchte, A., Farrugia, K., Sebra, R., Gitman, M., Nowak, M., Cordon-Cardo, C., et al. (2022) · Microbiology spectrum · doi:10.1128/spectrum.01736-22 · Cited by 4
Sustainable policy: Don't get infected and don't infect others
Takefuji, Y. (2022) · Journal of Hazardous Materials Advances · doi:10.1016/j.hazadv.2022.100165 · Cited by 6
Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics
Veleanu, A., Kelch, M. A., Ye, C.-J., Flohr, M., Wilhelm, A., Widera, M., Martínez-Sobrido, L., Ciesek, S., & Toptan, T. (2022) · Viruses · doi:10.3390/v14092017 · Cited by 5
Attenuation and Degeneration of SARS-CoV-2 Despite Adaptive Evolution
Liu, Y. (2023) · Cureus · doi:10.7759/cureus.33316 · Cited by 5
Self-citation
Investigation on the interaction mechanism of different SARS-CoV-2 spike variants with hACE2: insights from molecular dynamics simulations
Wu, J., Zhang, H., & Zhang, J. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp04349a · Cited by 6
A Protein Co-Conservation Network Model Characterizes Mutation Effects on SARS-CoV-2 Spike Protein
Zeng, L., Lu, Y., Yan, W., & Yang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043255 · Cited by 6
Combined Use of RT-qPCR and NGS for Identification and Surveillance of SARS-CoV-2 Variants of Concern in Residual Clinical Laboratory Samples in Miami-Dade County, Florida
Carattini, Y., Griswold, A. J., Williams, S. L., Valiathan, R., Zhou, Y., Shukla, B. S., Abbo, L. M., Parra, K., Jordà, M., Nimer, S. D., et al. (2023) · Viruses · doi:10.3390/v15030593 · Cited by 6
Genomic architecture and evolutionary relationship of BA.2.75: A Centaurus subvariant of Omicron SARS-CoV-2
Basheer, A., Zahoor, I., & Yaqub, T. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281159 · Cited by 6
SARS-CoV-2 utilization of ACE2 from different bat species allows for virus entry and replication in vitro
Briggs, K., Sweeney, R., Blehert, D. S., Spackman, E., Suarez, D. L., & Kapczynski, D. R. (2023) · Virology · doi:10.1016/j.virol.2023.07.002 · Cited by 5
Genetic characteristics of SARS-CoV-2 virus variants observed upon three waves of the COVID-19 pandemic in Ukraine between February 2021–January 2022
Gerashchenko, G. V., Hryshchenko, N. V., Melnichuk, N., Marchyshak, T., Chernushyn, S. Y., Demchyshina, I. V., Chernenko, L. M., Kuzin, I., Tkachuk, Z. Y., Kashuba, V. I., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25618 · Cited by 7
Calpain-2 mediates SARS-CoV-2 entry via regulating ACE2 levels
Zeng, Q., Antia, A., Casorla-Perez, L. A., Puray‐Chavez, M., Kutluay, S. B., Ciorba, M. A., & Ding, S. (2024) · mBio · doi:10.1128/mbio.02287-23 · Cited by 7
Within-host evolution of SARS-CoV-2: how often are de novo mutations transmitted from symptomatic infections?
Korosec, C. S., Wahl, L. M., & Heffernan, J. M. (2024) · Virus Evolution · doi:10.1093/ve/veae006 · Cited by 6
Variation in structural motifs within SARS-related coronavirus spike proteins
Hills, F. R., Eruera, A.-R., Hodgkinson‐Bean, J., Jorge, F., Easingwood, R. A., Brown, S. H. J., Bouwer, J. C., Li, Y., Burga, L. N., & Bostina, M. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012158 · Cited by 6
SARS‐CoV‐2 Evolution: Immune Dynamics, Omicron Specificity, and Predictive Modeling in Vaccinated Populations
Zhang, X., Li, M., Zhang, N., Li, Y., Teng, F., Li, Y., Zhang, X., Xu, X., Li, H., Zhu, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202402639 · Cited by 5
Self-citation
Quantifying multi-virion aerosols in respiratory infection transmission
Cheng, P., Jia, W., Liu, L., Yen, H., & Li, Y. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.136040 · Cited by 6
Synergistic evolution: The dynamic adaptation of SARS-CoV-2 and human protective immunity in the real world
Li, Y., Zhang, X., Yi, J., Chen, Y., Liang, J., Wang, K., Ma, J., Zhu, R., Zhang, X., Hu, D., et al. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106310 · Cited by 6
Self-citation
A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions
Soliman, M. S., AbdelFattah, M., Aman, S. M. N., Ibrahim, L. M., & Aziz, R. K. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2020.0194 · Cited by 6
The 442th amino acid residue of the spike protein is critical for the adaptation to bat hosts for SARS-related coronaviruses
Li, J., Wang, Q., Liao, C.-H., Qiu, Y., & Ge, X. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198307 · Cited by 6
Early Diffusion of SARS-CoV-2 Infection in the Inner Area of the Italian Sardinia Island
Piras, G., Grandi, N., Monne, M. I., Asproni, R., Fancello, T., Fiamma, M., Mameli, G., Casu, G., lo Maglio, I., Palmas, A. D., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.628194 · Cited by 6
Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target
Hong, J., Jhun, H., Choi, Y.-O., Taitt, A. S., Bae, S., Lee, Y.-M., Song, C., Yeom, S. C., & Kim, S. (2021) · Immune Network · doi:10.4110/in.2021.21.e8 · Cited by 6

Authors: Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., Mirchandani, D., Scharton, D., Bilello, J. P., Ku, Z., An, Z., Kalveram, B., Freiberg, A. N., Menachery, V. D., Xie, X., Plante, K. S., Weaver, S. C., & Shi, P.-Y.
Affiliations: The University of Texas Medical Branch at Galveston (US)
Gilead Sciences (United States) (US)
Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (US)
Corresponding author: Xie, Xuping
Plante, Kenneth S.
Weaver, Scott C.
Shi, Pei-Yong
ORCID: Plante, Jessica A.
Liu, Jianying
Xia, Hongjie
Johnson, Bryan A.
Zhang, Xianwen
Zou, Jing
Fontes-Garfias, Camila R.
Scharton, Dionna
Bilello, John P.
Ku, Zhiqiang
An, Zhiqiang
Freiberg, Alexander N.
Menachery, Vineet D.
Xie, Xuping
Plante, Kenneth S.
Weaver, Scott C.
Shi, Pei-Yong
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2020-10-26
Volume: 592
Issue: 7852
Pages: 116-121
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/s41586-020-2895-3
PMC: PMC8158177
OpenAlex: W3093768302
Cited by: 1,558
References: 37
Citations by year: 2026: 37 · 2025: 73 · 2024: 120 · 2023: 174 · 2022: 427 · 2021: 670 · 2020: 55
FWCI: 43.60
Type: journal article
Language: en
Update notices: correction (2021-06-15)
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
PubMed Central (submittedVersion, cc-by-nc-nd)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Amon G. Carter Foundation
John S. Dunn Foundation (AI145617)
University of Texas System
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (AI134907)
National Institutes of Health (AG049042, TL1TR001440, AI145617, AI142759, UL1TR001439)
National Institute on Aging (AI142759, AG049042, R00AG049092)
National Institute of Allergy and Infectious Diseases (R43AI145617, AI142759, R24AI120942, R01AI134907, R21AI145400, U01AI151801, U19AI142759, R01AI153602, AI153602, AG049042, AI134907, AI145617, UC7AI094660)
National Center for Advancing Translational Sciences
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords: SARS-CoV-2, viral fitness, viral replication, upper respiratory tract infection, virus transmission, neutralizing antibodies, vaccine efficacy, hamster model, lung epithelial cells, therapeutic antibodies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Spike mutation D614G alters SARS-CoV-2 fitness

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks